您的位置:首页 > 产品中心 > 91896-57-0, CP-66713
CP-66713
产品别名
91896-57-0
CP-66713
8-chloro-1-phenyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
PF-1716311
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C15H10ClN5 |
Molecular weight | 295.73 |
MDL number | MFCD17215961 |
PubChem Substance ID【PubChem化学物质编号】 | 329823714 |
NACRES | NA.77 |
Biochem/physiol Actions【生化/生理作用】 | CP-66713 is an adenosine A2 receptor antagonist. |
Features and Benefits【特点和优势】 | This compound is featured on the Adenosine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
Other Notes【其他说明】 | This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
Quality Level【质量水平】 | 100 |
Assay【测定】 | ≥98% (HPLC) |
form【形式】 | powder |
manufacturer/tradename | Pfizer® |
color【颜色】 | white to off-white |
solubility【溶解性】 | DMSO: ≥5 mg/mL |
originator【创始人】 | Pfizer |
storage temp.【储存温度】 | 2-8℃ |
SMILES string | Nc1nc2ccc(Cl)cc2n3c(nnc13)-c4ccccc4 |
InChI | 1S/C15H10ClN5/c16-10-6-7-11-12(8-10)21-14(9-4-2-1-3-5-9)19-20-15(21)13(17)18-11/h1-8H,(H2,17,18) |
InChI key | PBENJWAFQLORQL-UHFFFAOYSA-N |
packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
Pictograms【象形图】 | GHS07 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H302 - H315 - H319 - H335 |
Precautionary Statements | P261 - P305 + P351 + P338 |
Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
Target Organs【靶器官】 | Respiratory system |
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 3 |